Position in ARQT
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$117,346,940
-$78,905,553 QoQ
Shares Held
4,980,770
-26.3% QoQ
Ownership
3.98%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority
Sole 93.00174471015525.ToString("F0")%
Shared 0.ToString("F0")%
None 6.998255289844743.ToString("F0")%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JENNISON ASSOCIATES LLC holds $3,287,290,858 across 47 Biotechnology names. ARQT ranks #5 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,740,059 | $1,223,545,945 | |
| 2 | ARGX |
Argenx SE
|
237,468 | $173,411,007 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
3,340,492 | $164,218,586 | |
| 4 | TARS |
Tarsus Pharmaceuticals, Inc.
|
1,712,124 | $120,105,497 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
This page
|
4,980,770 | $117,346,940 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
1,072,011 | $112,989,959 | |
| 7 | INSM |
INSMED Inc
|
604,694 | $98,879,562 | |
| 8 | PCVX |
Vaxcyte, Inc.
|
1,698,011 | $98,671,418 |
All Filings in ARQT
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $117,346,940 | 4,980,770 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $196,252,493 | 6,758,006 | Shares | Defined | 2026-01-30 | |
| 2025-12-31 | $196,252,494 | 6,758,006 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $230,990,142 | 12,254,119 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $155,753,858 | 11,109,405 | Shares | Defined | 2025-08-01 | |
| 2025-03-31 | $177,684,084 | 11,360,875 | Shares | Defined | 2025-05-05 | |
| 2024-12-31 | $171,893,302 | 12,339,792 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $108,470,521 | 11,663,497 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $107,616,753 | 11,571,694 | Shares | Defined | 2024-08-05 | |
| 2024-03-31 | $120,667,281 | 12,176,315 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $29,283,443 | 9,066,082 | Shares | Defined | 2024-02-01 | |
| 2023-09-30 | $23,534,848 | 4,432,175 | Shares | Defined | 2023-10-31 | |
| 2023-06-30 | $40,921,494 | 4,293,966 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $24,359,390 | 2,214,490 | Shares | Defined | 2023-04-26 | |
| 2022-12-31 | $20,694,528 | 1,398,279 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $26,555,560 | 1,389,616 | Shares | Defined | 2022-11-01 | |
| 2022-06-30 | $9,270,254 | 435,019 | Shares | Defined | 2022-08-02 | |
| No filing history on record for this holder in this stock. | ||||||